Historical Stock Price
CATB historical stock prices picture
CATB (CATB) has the following price history information. Looking back at CATB historical stock prices for the last five trading days, on September 01, 2021, CATB opened at $10.00, traded as high as $10.19 and as low as $9.37, and closed at $9.41. Trading volume was a total of 83.50K shares. On September 02, 2021, CATB opened at $9.60, traded as high as $10.26 and as low as $9.60, and closed at $10.06. Trading volume was a total of 109.90K shares. On September 03, 2021, CATB opened at $10.07, traded as high as $10.18 and as low as $9.44, and closed at $9.53. Trading volume was a total of 81.90K shares. On September 07, 2021, CATB opened at $9.57, traded as high as $9.68 and as low as $8.95, and closed at $9.18. Trading volume was a total of 94.10K shares. On September 08, 2021, CATB opened at $9.21, traded as high as $9.21 and as low as $8.46, and closed at $8.54. Trading volume was a total of 98.80K shares.

CATB Historical Stock Prices By Date:

CATB historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CATB shares, starting with a $10,000 purchase of CATB, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/26/2015
End date: 09/08/2021
Start price/share: $808.20
End price/share: $8.54
Dividends collected/share: $0.00
Total return: -98.94%
Average Annual Total Return: -51.95%
Starting investment: $10,000.00
Ending investment: $105.65
Years: 6.21
Date Open High Low Close Volume
09/01/2021 $10.00 $10.19 $9.37 $9.41 83.50K
09/02/2021 $9.60 $10.26 $9.60 $10.06 109.90K
09/03/2021 $10.07 $10.18 $9.44 $9.53 81.90K
09/07/2021 $9.57 $9.68 $8.95 $9.18 94.10K
09/08/2021 $9.21 $9.21 $8.46 $8.54 98.80K
Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. Co.'s primary product candidate is edasalonexent, an oral small molecule that inhibits nuclear factor kappa-light-chain-enhancer of activated B cells in development for the treatment of Duchenne muscular dystrophy. Co. has also developed CAT-5571 as a potential treatment for cystic fibrosis (CF). CAT-5571 is an oral small molecule that is designed to activate autophagy, a mechanism for recycling cellular components and digesting pathogens, which is important for host defenses and is depressed in CF.
Date Close
09/01/2021$9.41
09/02/2021$10.06
09/03/2021$9.53
09/07/2021$9.18
09/08/2021$8.54
CATB is categorized under the Healthcare sector; below are some other companies in the same sector:

CATS Historical Stock Prices
CBAY Historical Stock Prices
CBIO Historical Stock Prices
CBLI Historical Stock Prices
CBM Historical Stock Prices
CBMG Historical Stock Prices
CBMX Historical Stock Prices
CBMXW Historical Stock Prices
CBPO Historical Stock Prices
CBRX Historical Stock Prices

Also explore: CATB shares outstanding history

Email EnvelopeFree CATB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CATB Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.